Comments on: Laboratory tests for the management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants: Proposals of the Working Group on Perioperative Haemostasis (GIHP): A rebuttal

Archives of Cardiovascular Diseases

Volumn 107, Issue 5, 2014, Pages 346-347

  Pernod, Gilles ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Direct oral anticoagulants; Haemorrhages; Laboratory tests; Surgery

Indexed keywords

ANTICOAGULANT AGENT; DABIGATRAN; RIVAROXABAN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A INHIBITOR; COAGULATING AGENT;

EMERGENCY SURGERY; HUMAN; LABORATORY TEST; LETTER; OPERATIVE BLOOD LOSS; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PROTHROMBIN TIME; BLOOD CLOTTING; DRUG EFFECTS; HEMORRHAGE; HEMOSTASIS; SURGERY;

ANTICOAGULANTS; ANTITHROMBINS; BLOOD COAGULATION; COAGULANTS; FACTOR XA INHIBITORS; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84903303706     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2014.04.007     Document Type: Letter

References (2)

1. A. Tripodi, D. Di Minno, and M. Moia Comments on: laboratory tests for the management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants: proposals of the Working Group on Perioperative Haemostasis (GIHP) Arch Cardiovasc Dis 107 2014 337 338 10.1016/j.acvd.2014.04.003
2. G. Pernod, P. Albaladejo, A. Godier, C.M. Samama, S. Susen, and Y. Gruel et al. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013 Arch Cardiovasc Dis 106 2013 382 393